Microbot Medical raises ~$7.6M from option exercises, receives NIS 2.15M IIA grant

Microbot Medical Inc.

Issued 4,344,286 shares at $1.75 upon exercise of Series G options, gross proceeds $7.6M.
Approved for non-dilutive grant of NIS 2.15M (~$630k) from Israel Innovation Authority.
Grant to enhance manufacturing capabilities for LIBERTY System as FDA clearance decision nears.
CFO states grant reflects high confidence in scaling manufacturing and meeting business objectives.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.